Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00215033 · ClinicalTrials.gov registry record
Relationship Between EBV and PTLD
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
- 160
- Enrollment target
NCT00215033: Clinical Trial study, sponsored by Children's Healthcare of Atlanta.
NCT00215033 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 160 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00215033 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
- 160 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the significance of an elevated quantitative EBV PCR and to determine the relationship between a EBV PCR value and the risk of developing PTLD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2005-04 |
| Est. Completion | 2006-05 |
Why NCT00215033 stopped before completion
NCT00215033 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00215033 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00215033 about?
NCT00215033 is a clinical study titled "Relationship Between EBV and PTLD". The purpose of this study is to determine the significance of an elevated quantitative EBV PCR and to determine the relationship between a EBV PCR value and the risk of developing PTLD.
What is the current status of trial NCT00215033?
This trial is currently terminated. The enrollment target is 160 participants. The study started on 2005-04. Estimated completion is 2006-05.
Who is sponsoring clinical trial NCT00215033?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia